Myotonic Dystrophy: all 126 studies
Page 1 of 2. Open to participants first (50), then studies with results posted, then the rest; newest registration first within each.
- Metabolomic Biomarkers of Myotonic DystrophyRecruitingNCT07912983
- An Ambispective Natural History Study in Myotonic Dystrophy Patients Linking Retrospective Data Captured From the DM-Scope Registry With a Prospective 24-month Follow-up PeriodNot yet recruitingNCT07732439
- Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) ExtensionRecruitingNCT07700225
- Remote Assessments and Genetic Determinants of Congenital and Childhood Myotonic DystrophyRecruitingNCT07630389
- Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)RecruitingNCT07608432Phase 3
- A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 SkippingRecruitingNCT07587242Phase 3
- Remote Assessments and Genetic Determinants of Myotonic DystrophyRecruitingNCT07505342
- Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1RecruitingNCT07486934Phase 3
- Evaluation of the Role of miR-1 in the Pathogenesis and as a Biomarker in Muscular Dystrophies and Congenital MyopathiesRecruitingNCT07415837Not applicable
- The Spanish National Registry for Myotonic Dystrophy Type 1RecruitingNCT07385443
- Development of Quantitative Muscle Imaging as a Biomarker of Disease Endpoints in Myotonic DystrophyRecruitingNCT07362875
- Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic VolunteersRecruitingNCT07321977Not applicable
- An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)RecruitingNCT07220603Phase 2
- Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic PathologyRecruitingNCT07136844Not applicable
- Tideglusib: Expanded Access Use in Congenital Myotonic DystrophyAvailableNCT07119775
- Calcium Channel Blocker in Myotonic Dystrophy Type 1Not yet recruitingNCT07075965Phase 1
- The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.Enrolling by invitationNCT07072676Not applicable
- Global Open-Label Extension Study of Del-desiran for the Treatment of DM1Enrolling by invitationNCT07008469Phase 3
- A Registered Observational Cohort Study of Myotonic Dystrophy Type 1Enrolling by invitationNCT06979024
- A Study of Long-term Safety and Efficacy of VX-670 in Participants With Myotonic Dystrophy Type IEnrolling by invitationNCT06926621Phase 2
- A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1RecruitingNCT06844214Phase 1/2
- Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac TransplantationRecruitingNCT06813443
- Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy ExtensionRecruitingNCT06747884
- Investigating Exercise in Myotonic Dystrophy Type 2 (DM2)RecruitingNCT06716931Not applicable
- Personalized Training for People With Rare Neuromuscular DisordersRecruitingNCT06708468Not applicable
- A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1RecruitingNCT06667453Phase 2
- Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular DisordersEnrolling by invitationNCT06605612
- Wheelchair Skills Training for People with ARSACS and DM1Not yet recruitingNCT06596850Not applicable
- An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2 Who Have Completed MEX-DM-302 Study.Enrolling by invitationNCT06549400Phase 3
- The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2RecruitingNCT06523400Phase 3
- Myotonic Dystrophy Type 1 Congenital and Juvenile Form: From Diagnosis to Rehabilitation [MDCJ-NeuBeRe]RecruitingNCT06378216
- Pelvic Floor Muscle Training for Women with Myotonic DystrophyRecruitingNCT06316778Not applicable
- Study of ATX-01 in Participants With DM1RecruitingNCT06300307Phase 1/2
- Development of Non-Invasive Prenatal Diagnosis for Single Gene DisordersRecruitingNCT06147414
- Study of SRP-1003 in Participants With Type 1 Myotonic DystrophyEnrolling by invitationNCT06138743Phase 1/2
- Chinese Multicenter Clinical Outcome Cohort Study of Myotonic Dystrophy Type 1 (C-DMCOS-DM1)Enrolling by invitationNCT06101940
- Cerebrospinal Fluid Biomarkers of Myotonic DystrophyRecruitingNCT06075693
- Long-Term Development of Muscular Dystrophy Outcome AssessmentsRecruitingNCT05989620
- Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next StudyRecruitingNCT05982119Not applicable
- Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2Enrolling by invitationNCT05854433
- Home-based Training and Supplementation in DM1 PatientsNot yet recruitingNCT05848830Phase 3
- Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease)RecruitingNCT05532813Phase 3
- DMCRN-02-001: Assessing Pediatric Endpoints in DM1RecruitingNCT05224778
- Biomarker Development for Muscular DystrophiesRecruitingNCT05019625
- Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic DystrophyRecruitingNCT05004129Phase 2/3
- The United Kingdom National Registry for Myotonic DystrophyRecruitingNCT04003363
- Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)RecruitingNCT03981575
- Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac ArrhythmiasEnrolling by invitationNCT02413450
- Myotonic Dystrophy Family RegistryRecruitingNCT02398786
- Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy RegistryRecruitingNCT00082108
- Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) PatientsCompletedNCT05027269Phase 1/2Results posted
- Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1CompletedNCT04886518Phase 2Results posted
- Safety, Tolerability and Pharmacokinetics of ERX-963 in Adults With Myotonic Dystrophy Type 1CompletedNCT03959189Phase 1Results posted
- Efficacy and Safety of Tideglusib in Congenital Myotonic DystrophyCompletedNCT03692312Phase 2/3Results posted
- Study of Tideglusib in Adolescent and Adult Patients With Myotonic DystrophyCompletedNCT02858908Phase 2Results posted
- Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1CompletedNCT01406873Phase 2Results posted
- Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1CompletedNCT00577577Phase 2Results posted
- Effects of SomatoKine (Iplex)Recombinant Human Insulin-like Growth Factor-1/Recombinant Human Insulin-like Growth Factor-binding Protein-3 (rhIGF-I/rhIGFBP-3) in Myotonic Dystrophy Type 1 (DM1)CompletedNCT00233519Phase 1/2Results posted
- Telerehabilitation Hand Training for Patients With Neuromuscular ConditionsCompletedNCT07926971Not applicable
- Fall Frequency and Factors Affecting Dynamic Balance in Patients With Myotonic Dystrophy Type 1Active, not recruitingNCT07493525
- Longitudinal Evaluation of Neuromuscular Involvement in Type 1 Myotonic DystrophyCompletedNCT07362316
- Music Intervention for Brain-Heart Disease in Myotonic Dystrophy Type 1 (DM1)Active, not recruitingNCT06809049Not applicable
- Global Study of Del-desiran for the Treatment of DM1CompletedNCT06411288Phase 3
- Trial Readiness and Endpoint Assessment in Congenital and Childhood Myotonic DystrophyCompletedNCT06276244
- Evaluation of Cognitive Functions in 20 Patients With Type 1 Myotonic Dystrophy With Virtual Reality ApproachWithdrawnNCT06270186Not applicable
- Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1CompletedNCT06204809Phase 1
- A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)Active, not recruitingNCT06185764Phase 1/2
- Observational Study of Digital Biomarkers of Myotonia and Gait in Adults and Children With Myotonic DystrophyActive, not recruitingNCT06089018
- Virtual Reality-training in Theory of Mind in the Childhood Form of Myotonic Dystrophy Type 1CompletedNCT05916677Not applicable
- The Risk of Falls Index for Patients With Neuromuscular DisordersCompletedNCT05890833
- Profile of Dysphagia in Myotonic Dystrophy Type 1 (DM1)CompletedNCT05865483
- Low-frequency Repetitive Nerve Stimulation in Myotonic Dystrophy Type 1CompletedNCT05662150Not applicable
- Technology Assisted Rehabilitation for Upper Limb Function in Myotonic Dystrophy Type 1CompletedNCT05560438Not applicable
- Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1Active, not recruitingNCT05481879Phase 1/2
- Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) PatientsCompletedNCT05479981Phase 2
- Effects of a 12-week Strength Training Program in Women With Myotonic Dystrophy Type 1CompletedNCT05400629Not applicable
- A Remote Physical Activity Program in the Population Suffering from Type 1 Myotonic DystrophyActive, not recruitingNCT05072288Not applicable
- Myotonic Dystrophy Type 1 and Resistance ExerciseCompletedNCT05036447Not applicable
- Extracellular RNA Biomarkers of Myotonic DystrophyActive, not recruitingNCT05020002
- Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1CompletedNCT05006924
- Musculoskeletal Nociceptive Pain in Participants With Neuromuscular DisordersCompletedNCT04907162
- Breathlessness Assessment in Adult Patients With Myotonic Dystrophy Type 1CompletedNCT04835298
- Poor Neck Proprioception May Cause Balance Deficits in Myotonic Dystrophy 1CompletedNCT04712422
- Study to Investigate the Efficacy and Safety of Mexiletine in Patients With Myotonic Dystrophy Type 1 and Type 2WithdrawnNCT04700046Phase 3
- NIPD on cffDNA for Triplet Repeat DiseasesStatus unknownNCT04698551
- Myotonic Dystrophy - Vascular and CognitionActive, not recruitingNCT04656210
- Effect of MYODM on Quality of Life, Fatigue and Hypersomnia in Patients With Myotonic Dystrophy Type 1CompletedNCT04634682Not applicable
- Open Label Study in Adolescents and Children With Myotonic DisordersCompletedNCT04624750Phase 3
- An Observational Study in Adult Patients With Non-dystrophic Myotonic DisordersCompletedNCT04616807
- Myotonic Dystrophy Type 1 Aerobic Exercise StudyCompletedNCT04187482Not applicable
- DM-IMT - Controlled, Randomized, Three-arm Intervention Study on the Safety and Efficacy of Regular Respiratory Muscle Training in Patients With Myotonic Dystrophy Type 1CompletedNCT04052958Not applicable
- Effects of a 12-week Strength Training Program in Men With Myotonic Dystrophy Type 1CompletedNCT04018820Not applicable
- Effects of a Multiple Component Training Program on Muscles in Adults With Myotonic Dystrophy Type 1CompletedNCT04001920Not applicable
- Sudden Cardiac Death Stratification in Myotonic Dystrophy Type 1 PatientsStatus unknownNCT03784586
- Factors Associated With Hypoventilation in the Myotonic Dystrophy, Progressive Profile Over 5 YearsCompletedNCT03764150
- Clinical Outcome Measures in Myotonic Dystrophy Type 2CompletedNCT03603171
- Brain Involvement in Myotonic Dystrophy Type I: From Functional Neuroimaging to the Impact on Quality of LifeCompletedNCT03589677
- Venous Thromboembolism in Myotonic Dystrophy Type 1CompletedNCT03424460Not applicable
- Muscle Relaxation in Myopathies With Positive Muscle PhenomenaStatus unknownNCT03211923
- Venous Thromboembolism in DM1CompletedNCT03141749